LÜBECK. Dr. med. Holger K. Eltzschig, managerial head of department of University Hospital Tübingen/Germany, wins this year’s Heinrich-Dräger-Award for intensive medicine.
Stefan Dräger, Chief Executive Offier of Drägerwerk AG, handed out the 10,000 Euro-endowed award at the opening of the German Anaesthesia Congress (Deutscher Anästhesie Congress, DAC) in Leipzig on May 17 2006.
37-year-old Eltzschig prevailed against his competitors with his scientific work “HIF-1-unabhängige Repression der equilibrativen Nukleosidtransporter (ENT) unter Hypoxie” („HIF-1-independent repression of equilibrative nucleoside transporters (ENT) under hypoxia”). Every year, Drägerwerk awards essential research works in the field of intensive medicine which were published in national and international expert magazines. Eltzschig’s work which is a co-operation between his team and Harvard Medical School Boston deals with adjustment of different organs and tissues towards a lack of oxygen (hypoxia). The scientists figured out that the second messenger adenosine develops a protective effect when at a lack of oxygen adenosine-evacuation is reduced by adenosine transporters. This knowledge helps to identify new therapeutic target values and moreover new treatment strategies, especially in the case of intensive medicine diseases.
Heinrich Dräger, innovative and with an inventing spirit, founded Drägerwerk in 1889. Due to his outstanding labour, the award was named after him.
The photograph beneath shows (from left to right):
Stefan Dräger, Chief Executive Officer Drägerwerk AG,
laureate Dr. med. Holger K. Eltzschig and
Prof. Dr. med. Joachim Radke, president DGAI/Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin